MapLight Therapeutics, Inc.
MPLT
$13.71
-$0.24-1.72%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.11M | 10.82M | 18.75M | 4.40M | 3.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.55M | 64.50M | 83.38M | 31.50M | 30.66M |
| Operating Income | -63.55M | -64.50M | -83.38M | -31.50M | -30.66M |
| Income Before Tax | -60.19M | -60.67M | -79.55M | -29.42M | -29.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -60.19M | -60.67M | -79.55M | -29.42M | -29.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.19M | -60.67M | -79.55M | -29.42M | -29.85M |
| EBIT | -63.55M | -64.50M | -83.38M | -31.50M | -30.66M |
| EBITDA | -63.40M | -64.34M | -83.24M | -31.36M | -30.53M |
| EPS Basic | -1.32 | -1.34 | -2.47 | -37.18 | -39.11 |
| Normalized Basic EPS | -0.83 | -0.85 | -1.57 | -23.24 | -24.45 |
| EPS Diluted | -1.32 | -1.34 | -2.47 | -37.18 | -39.11 |
| Normalized Diluted EPS | -0.83 | -0.85 | -1.57 | -23.24 | -24.45 |
| Average Basic Shares Outstanding | 45.43M | 45.28M | 32.15M | 791.10K | 763.00K |
| Average Diluted Shares Outstanding | 45.43M | 45.28M | 32.15M | 791.10K | 763.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |